澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

DIMERIX LTD

0.315

-0.005-1.56%

成交量：38.62萬

成交額：12.25萬

市值：1.89億

市盈率：-11.26

高：0.325

開：0.315

低：0.310

收：0.320

52周最高：0.785

52周最低：0.310

股本：6.00億

流通股本：4.68億

量比：0.50

換手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):-0.028

每股收益(LYR):-0.024

淨資產收益率：-594.54%

總資產收益率：-58.27%

市淨率：-112.50

市盈率(LYR):-13.32

資料載入中...

總覽公司新聞資訊公告

BUZZ-澳大利亞 Dimerix 公司以 48 億美元出售資產，創下 7 個月新高

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DXB.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.315,"timestamp":1774586161901,"preClose":0.32,"halted":0,"volume":386198,"delay":0,"changeRate":-0.015625000000000014,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.027967,"marketStatus":"交易中","change":-0.005,"latestTime":"03-27 15:36:29 AEDT","open":0.315,"high":0.325,"low":0.31,"amount":122516,"amplitude":0.046875,"askPrice":0.325,"askSize":34606,"bidPrice":0.32,"bidSize":31397,"shortable":3,"etf":0,"ttmEps":-0.027967,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774587600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.32,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.504754,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.32,"auctionPrice":0.315,"auctionVolume":48662,"auctionTime":1774565948591,"referenceTime":1774517404089,"auction":1,"marketStatus":"盘前竞价","timestamp":1774565948591}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-58.27%","roe":"-594.54%","lyrEps":-0.023645,"volumeRatio":0.504754,"shares":600396776,"dividePrice":0,"high":0.325,"amplitude":0.046875,"preClose":0.32,"low":0.31,"week52Low":0.31,"pbRate":"-112.50","psRate":"25.50","week52High":0.785,"institutionHeld":0,"latestPrice":0.315,"committee":-0.048619,"eps":-0.027967,"divideRate":0,"volume":386198,"delay":0,"ttmEps":-0.027967,"open":0.315,"prevYearClose":0.55,"prevWeekClose":0.325,"prevMonthClose":0.475,"prevQuarterClose":0.55,"fiveDayClose":0.325,"twentyDayClose":0.475,"sixtyDayClose":0.55,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593103120","title":"BUZZ-澳大利亞 Dimerix 公司以 48 億美元出售資產，創下 7 個月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103120","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103120?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 12:10","pubTimestamp":1766376617,"startTime":"0","endTime":"0","summary":"12月22日 - ** DimerixDXB.AX股价上涨12.5%至0.63澳元，创七个月来最高水平** 如果涨势得以保持，该股将创下六个月来的最大盘中涨幅** 生物技术公司称美国上市生物技术公司 BioMarin Pharmaceutical BMRN.O将以 48 亿美元收购  公司的美国商业许可合作伙伴 Amicus Therapeutics。** Amicus Therapeutics 是一家生物制药公司，负责向美国市场授权 DXB 的 DMX-200 药物，用于治疗罕见肾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL4S3XS07W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE0002270589.USD","BK7508","LU2065171311.SGD","BK7067","DXB.AU","LU2065170008.USD","LU2065171402.SGD","FOLD","BMRN","BK4139","BK4566","IE00B7SZLL34.SGD","LU2065169927.USD","BK7501","IE00B19Z3581.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}